Option chain shows key data for MEDIROM Healthcare Techs's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for MEDIROM Healthcare Techs.

MEDIROM Healthcare Techs (NASDAQ:MRM) Stock, Option Chain

MEDIROM Healthcare Techs

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Stocks.Watch_.Shutterstock

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ACCD

PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday

Crude-oil-4-logo

Equities

Eurozone

Commodities

ALAR

NSSC

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Crude Oil Rises Sharply; Daqo New Energy Reports Weak Q2 Results

Wall Street, US stocks

$ETH

Nasdaq Dips 1%; US Durable Goods Orders Increase In July

MEDIROM Healthcare Technologies Inc. - American Depositary Share

MEDIROM Healthcare Technologies Inc

MMA Offshore Ltd

MariMed Inc

MIRAMAR RESOURCES LTD by MIRAMAR RESOURCES LTD

MRMAX HLDGS LTD by MRMAX HLDGS LTD

<a href="https://www.globenewswire.com/Tracker?data=PomMWl7Q68X2BTRC0CL0p5s4xRBZn71wIxRXWp39fmpV7yGoHGELGOweHf8o6ULXFuodz6A96pD8bAqGBxPtwA==">LogicMark, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) (the "Company"), a provider of personal emergency response systems (PERS), health communications devices, and technology for the growing care economy, today announced that the Company's board of directors has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 25 pre-split shares.
The Company's board of directors also approved a corresponding 1-for-25 reverse stock split ratio for its Series C preferred stock, which will occur simultaneously with the reverse stock split of its common stock. The reverse stock splits were approved at a Special Meeting of Stockholders, held on October 1, 2024, and the reverse stock split of the common stock is intended to bring the Company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing on the Nasdaq Capital Market. The Company expects that the common stock will begin trading on a split-adjusted basis at the open of trading on Tuesday, November 19, 2024, under the new CUSIP number 67091J 602, and each of the reverse stock splits will be effective as of 5:00 p.m. Eastern Time on November 18, 2024, upon the filing of the applicable certificates with the Secretary of State of the State of Nevada.

Stock Split

LGMK

LogicMark, Inc. Announces 1-For-25 Reverse Stock Splits, Expects That The Common Stock Will Begin Trading On A Split-Adjusted Basis At The Open Of Trading On Tuesday, November 19, 2024, Under The New CUSIP Number, 67091J 602

Goldman Sachs analyst Brooke Roach maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Buy and raises the price target from $58 to $66.

Price Target

Analyst Ratings

Goldman Sachs Maintains Buy on Tapestry, Raises Price Target to $66

Macro Economic Events

Econ #s

Economics

USA Manufacturing Production (MoM) For October -0.5% Vs -0.5% Est.; -0.3% Prior

<ul>
<li>TSLA</li>
<li>ASTS</li>
<li>LUNR</li>
<li>NVDA</li>
<li>RKLB</li>
<li>SMCI</li>
<li>BABA</li>
<li>AI</li>
<li>AMAT</li>
<li>LOT</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AMAT

ASTS

BABA

LUNR

NVDA

RKLB

SMCI

TSLA

Top 10 Trending Stocks On WallStreetBets As Of November 15, 2024 (Via Swaggy Stocks)

USA Industrial Production (MoM) For October -0.3% Vs -0.3% Est.; -0.5% Prior

Goldman Sachs analyst Caitlin Burrows maintains Tanger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKT#NYSE">SKT</a>) with a Neutral and raises the price target from $31 to $35.

Goldman Sachs Maintains Neutral on Tanger, Raises Price Target to $35

Compass CEO Robert Reffkin predicts Zillow, worth around $17 billion, will eventually become the nation's de facto Multiple Listing Service (MLS). This shift would <a href="https://www.benzinga.com/general/24/03/37919926/new-rule-change-could-be-worst-thing-ever-for-realtors-and-great-news-for-homebuyers-with-this-real">mark a significant change in real estate industry dynamics</a>. Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>‘Beating the market through ethical real estate investing' —<a href="https://www.benzinga.com/money/invest-with-roots"> this platform aims to give tenants equity in the homes they live in while scoring 17.38% average annual returns for investors – here&#8217;s how to join with just $100</a></li>
</ul>
Initially reported by Inman, the prediction came during a discussion at the National Association of Realtors (NAR) annual conference last Friday amid ongoing debates over listing policies.
&#8220;I think if you were going to build an MLS today … I think it would be national,&#8221; Reffkin said during the &#8220;Future of the MLS&#8221; session. &#8220;There wouldn&#8217;t be 548. At some point, there will be a national MLS.&#8221;
His comments come as the industry grapples with changes to commission structures and listing practices following a recent legal decision. The traditional model of seller-paid commissions is evolving, with new rules eliminating commission information from MLS listings.
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
Reffkin praised Zillow&#8217;s business strategy while criticizing existing industry rules. &#8220;They were able to get access to all the listings and then charge referral fees on all the listings. It&#8217;s a great business model and those are rules that you&#8217;ve created, so they&#8217;re the winner,&#8221; he said.
Zillow&#8217;s Chief Industry Development Officer, Errol Samuelson, defended the current MLS system. &#8220;At its essence, the reason the MLS is so important is it is an unbiased, open, two-sided marketplace where there is equal access to information,&#8221; Samuelson said. &#8220;If it didn&#8217;t exist, we would feel obliged to invent it.&#8221;
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
The debate intensifies as the industry adapts to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37798094/settlement-shake-up-nars-418m-agreement-reshapes-real-estate-dynamics">court-mandated changes in agent compensation</a>. Traditional practices of sellers paying both agents&#8217; commissions face scrutiny, with new requirements for explicit buyer-broker agreements.
&#8220;Any time we have the opportunity to have a conversation with the consumer about the value that we bring to the transaction … that&#8217;s a good thing,&#8221; NAR President Kevin Sears said, addressing the broader changes in commission structures, in an August USA Today report.
According to Stephen Brobeck of the Consumer Federation of America, the evolving landscape could reshape the industry within five years. &#8220;For consumers, things are not going to change much in the immediate future,&#8221; Brobeck told USA Today. &#8220;But it&#8217;s like a dam that&#8217;s springing a leak.&#8221;
See Also: This company is giving accredited investors an opportunity to invest in this $2 billion fund, <a href="https://www.benzinga.com/money/ignite-funding">with three decades in business they boast an impressive track record of double-digit returns.</a>
The new rule threatens smaller brokerages while potentially strengthening Zillow&#8217;s market position, supporting Reffkin&#8217;s prediction about the future of listing services in America.
Art Carter, CEO of California Regional MLS, highlighted the difficulty of managing industry changes across diverse stakeholder interests. &#8220;My top three brokers all have three different opinions on policy,&#8221; Carter said. The debate over listing policies and market structure continues as the industry searches for a balance between traditional practices and technological innovation in an increasingly digital real estate landscape.
Read Next:
<ul>
<li>Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Real Estate

$17 Billion Zillow To Become The MLS, Predicts Compass CEO In NAR Showdown

Federal employees are concerned over President-elect Donald Trump&#8217;s pick, Robert F. Kennedy Jr., to lead the Department of <a href="https://www.benzinga.com/government/regulations/24/11/41993115/trump-taps-rfk-jr-for-health-secretary-role-sends-5-vaccine-stocks-lower" target="_blank" rel="noreferrer noopener">Health and Human Services</a>.
What Happened: Employees within the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) are worried about Kennedy being in charge, given his critical stance on mainstream medical practices and vaccines.
Kennedy, who received Trump&#8217;s blessing to &#8220;<a href="https://www.benzinga.com/markets/cannabis/24/11/41828359/could-trumps-go-wild-on-health-invite-to-rfk-jr-drive-changes-for-cannabis-and-psychedelics">go wild on health</a>,&#8221; has stated intentions to overhaul various aspects of the federal health agencies. 
One plan is to slash the NIH&#8217;s 27 divisions to 15, according to NPR.
Joel Zinberg, a senior fellow at conservative think tanks, <a href="https://www.npr.org/2024/11/12/nx-s1-5183014/trump-election-2024-nih-rfk?utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=Scan%20Weds%202024-11-13&amp;utm_term=The%20Scan%20Bulletin" target="_blank" rel="noreferrer noopener">blamed</a> the pandemic for eroding public trust in agencies like the NIH and suggested that reforms might restore confidence.
See Also: <a href="https://www.benzinga.com/general/biotech/24/11/42006119/who-calls-vaccines-absolutely-critical-as-trumps-appointment-of-rfk-jr-pulls-pzifer-moderna-stocks-downhill">WHO Calls Vaccines &#8216;Absolutely Critical&#8217; As Trump&#8217;s Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill</a>
Why It Matters: Regarding the FDA, Kennedy will likely <a href="https://www.newsweek.com/rfk-jr-fda-departments-trump-presidency-1981671">eliminate</a> entire departments, such as the nutrition division. He also voiced plans <a href="https://www.benzinga.com/government/regulations/24/11/41936736/fda-commissioner-califf-candid-on-trumps-impact-we-just-dont-know-whats-going-to-happen" target="_blank" rel="noreferrer noopener">for broader reforms</a>.
Some employees are reportedly contemplating departure before Kennedy Jr. even arrives.
Former and current staff cited concerns stemming from Kennedy&#8217;s potential influence and previous positions as reasons for their apprehension.
One official <a href="https://www.nbcnews.com/health/health-news/fda-employees-consider-handle-rfk-jr-leaving-rcna180115" target="_blank" rel="noreferrer noopener">told</a> NBC News that despite initial concerns during Trump&#8217;s first term, there was &#8220;relatively little turnover,&#8221; with employees managing to align with new priorities, such as faster drug approval processes. 
However, the current atmosphere has a heightened sense of unease due to Kennedy&#8217;s potential involvement.
During an interview, FDA commissioner Robert Califf said he is &#8220;disappointed&#8221; about the election&#8217;s outcome. &#8220;I think we just don&#8217;t know what&#8217;s going to happen.&#8221;
While it remains to be seen what exact role Kennedy might hold, he has proposed an aggressive restructuring, including appointing new staff to replace 600 NIH employees.
Pharmaceutical Research and Manufacturers of America, a drug industry lobby group, <a target="_blank" href="https://phrma.org/resource-center/Topics/Leaders/PhRMA-Statement-on-HHS-Nomination" rel="noreferrer noopener">said</a>,&#8221; This industry is a crown jewel of the American economy, giving American patients more medicine choices than anywhere else in the world and supporting millions of high-paying, high-tech jobs around the country.
We want to work with the Trump administration to further strengthen our innovation ecosystem and improve health care for patients.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/41987123/blood-cancer-focused-blueprint-medicines-could-be-attractive-target-for-partnerships-analyst-initiates-with-around-30-upside" target="_blank" rel="noreferrer noopener">Blood Cancer-Focused Blueprint Medicines Could Be &#8216;Attractive Target For Partnerships&#8217;: Analyst</a></li>
</ul>
Image: Shutterstock

Biotech

Government

Health Care

Politics

General

Robert Kennedy Poised To Lead Health And Human Services: Why FDA, NIH Officials Are Nervous

Canaccord Genuity analyst Austin Moeller maintains Intuitive Machines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) with a Buy and raises the price target from $11 to $12.5.

Canaccord Genuity Maintains Buy on Intuitive Machines, Raises Price Target to $12.5

CNS Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 99.54 percent increase over losses of $(54.14) per share from the same period last year.

CNSP

CNS Pharmaceuticals Q3 EPS $(0.25) Misses $(0.12) Estimate

Goldman Sachs analyst Will Nance maintains Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) with a Neutral and raises the price target from $23.5 to $33.

Goldman Sachs Maintains Neutral on Paymentus Holdings, Raises Price Target to $33

On November 15, 2024, in connection with a one-for-two reverse stock split (the "Reverse Stock Split") of the common stock, $0.01 par value per share (the "Common Stock") of Wheeler Real Estate Investment Trust, Inc. (the "Company"), to be effective on November 18, 2024, the Company filed two Articles of Amendment to its charter with the State Department of Assessments and Taxation of Maryland that provide for:
 &nbsp;
i.a one-for-two Reverse Stock Split of the Common Stock, to be effective at 5:00 p.m. Eastern Time (the&nbsp;"Effective Time") on November 18, 2024 (the "First Amendment"); and
ii.the par value of the Common Stock to be decreased from $0.02 per share (as a result of the one-for-two Reverse Stock Split) to $0.01 per share, to be effective at 5:01 p.m. Eastern Time on November 18, 2024 (the "Second Amendment").
 &nbsp;
Pursuant to the First Amendment, no fractional shares will be issued in connection with the Reverse Stock Split; rather, stockholders who would have otherwise been issued a fractional share of the Common Stock as a result of the Reverse Stock Split will instead receive a cash payment in lieu of such fractional share in an amount equal to the applicable fraction multiplied by the closing price of the Company's Common Stock on The Nasdaq Capital Market on November 18, 2024 (as adjusted for the Reverse Stock Split), without any interest.
 &nbsp;
The foregoing descriptions of the amendments to the Company's charter do not purport to be complete and are qualified in their entirety by reference to each amendment, copies of which are filed as Exhibit 3.1 and Exhibit 3.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
 &nbsp;
Effect of Reverse Stock Split on Common Stock
 &nbsp;
At the market open on November 19, 2024 (the first business day after the Effective Time), the Common Stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market under a new CUSIP number (963025846).
 &nbsp;
The Reverse Stock Split will apply to all of the outstanding shares of Common Stock as of the Effective Time, with a corresponding adjustment to the outstanding partnership units of the Company's operating partnership, Wheeler REIT, L.P. It therefore will not affect any particular stockholder's relative ownership percentage of shares of Common Stock, except for de minimis changes resulting from the payment of cash in lieu of fractional shares. The Reverse Stock Split will also not affect the relative voting or other rights that accompany the shares of Common Stock, except to the extent that it results from a stockholder receiving cash in lieu of fractional shares. There will be no change to the number of authorized shares of the Common Stock as a result of the Reverse Stock Split. The Company's trading symbol will remain unchanged, but the CUSIP number for the Company's registered Common Stock will be changed to 963025846.
 &nbsp;
In connection with the Reverse Stock Split, adjustments will be made to the number of shares of Common Stock issuable upon conversion of the Company's convertible securities.
 &nbsp;

WHLR

Wheeler Real Estate Investment Trust Announces 1-For-2 Reverse Stock Split Effective November 18; Will Trade Under New CUSIP Number, 963025846

Canaccord Genuity analyst George Gianarikas maintains Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) with a Buy and lowers the price target from $1.5 to $1.25.

DFLI

Canaccord Genuity Maintains Buy on Dragonfly Energy Hldgs, Lowers Price Target to $1.25

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) with a Buy and lowers the price target from $6 to $3.5.

AKYA

Canaccord Genuity Maintains Buy on Akoya Biosciences, Lowers Price Target to $3.5

Goldman Sachs analyst Tito Labarta maintains PagSeguro Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAGS#NYSE">PAGS</a>) with a Buy and lowers the price target from $14 to $12.

PAGS

Goldman Sachs Maintains Buy on PagSeguro Digital, Lowers Price Target to $12

Vertically integrated cannabis operator Acreage Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRG#CSE">ACRG</a>, ACRG.B.U)) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ACRHF#OTCQX">ACRHF</a>, ACRDF)) reported its financial results Thursday for the third quarter ended Sept. 30, 2024.
"In the third quarter, we continued to focus on re-accelerating growth across our core states, including Connecticut, Illinois, and New Jersey, while also executing on the highly anticipated launch of non-medical sales in Ohio,&#8221; said CEO Dennis Curran. &#8220;With our strengthened financial position, we have bolstered our capacity to pursue opportunities in these markets as they continue to mature, which is expected to play a pivotal role in driving both revenue generation and improvements in Adjusted EBITDA as we close out 2024."
<h3 class="wp-block-heading">Q3 2024 Financial Highlights</h3>
<ul>
<li>Consolidated revenue totaled $39.6 million, representing a 30% decrease YoY.</li>
<li>Gross margin was 35%, down from 38% in the third quarter of 2023.</li>
<li>Total operating expenses amounted to $22.6 million, down from $24 million in the same period of last year.</li>
<li>Net loss was $22.2 million, up from a loss of $7.9 million in the previous year's quarter.</li>
<li>Adjusted EBITDA came in positive at $0.6 million, representing a drop from $6.6 million in the third quarter of 2023.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40398055/acreage-holdings-q2-revenue-drops-invests-in-ohio-growth-as-canopy-acquisition-nears">Acreage Holdings Q2 Revenue Drops, Invests In Ohio Growth As Canopy Acquisition Nears</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Q3 2024 Operational Highlights</h3>
<ul>
<li>Launched recreational cannabis sales in Ohio at five Botanist retail locations, contributing to 38% of third-quarter revenue in the state.</li>
<li>Debut Superflux flower in Illinois, with strong wholesale penetration.</li>
<li>Achieved record wholesale revenue performance in New York.</li>
<li>Secured a $65 million credit agreement, resulting in the repayment of prior debts.</li>
<li>Gained green light for a new dispensary in Collingswood, New Jersey.</li>
</ul>
<h3 class="wp-block-heading">Outlook</h3>
Canopy USA, Canopy Growth Corporation&#8216;s (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WEED#TSX">WEED</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) strategy to consolidate its U.S.-based assets &#8211; is set to acquire Acreage in 2025.
Curran emphasized efforts to boost growth in key markets like Connecticut, Illinois, and New Jersey while leveraging Acreage&#8217;s strong medical reputation in Ohio.
<h3 class="wp-block-heading">ACRHF Price Action</h3>
Acreage's shares traded 4.29% lower at $0.134 per share after the market close on Thursday afternoon.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40742561/ohios-cannabis-sales-reach-44m-as-new-customers-just-keep-coming-and-demand-is-not-slowing">Ohio&#8217;s Cannabis Sales Reach $44M As New Customers Just Keep Coming And Demand Is Not Slowing</a></li>
</ul>

Cannabis

ACRDF

ACRHF

CSE:ACRG

TSX:WEED

WEED

Canopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY

Dogecoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) 9% price pullback presents a potential buying opportunity, according to optimistic cryptocurrency traders on social media.
What Happened: After an 88% rally over the past week, Dogecoin has dropped 9% in Friday trading. 
On-chain tracker Lookonchain reported that a whale shifted all funds from the SPX meme coin to DOGE in the past two days, <a href="https://x.com/lookonchain/status/1857361643120058616">selling</a> 10.6 million SPX for $6.2 million and using the proceeds to buy 13.95 million DOGE worth $4.88 million.
Despite the dip, Dogecoin remains one of the top-performing meme coins:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.3749&nbsp;</td>
<td>$55 billion</td>
<td> -8.9%</td>
<td> +88%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00002426 </td>
<td>$14.3 billion</td>
<td> -6.1%</td>
<td>&nbsp;+27%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>&nbsp;$0.00002179&nbsp;&nbsp;</td>
<td>$9.1 billion</td>
<td> -1.3%</td>
<td> +97%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto analyst Ali Martinez predicts a 22% price move for DOGE, depending on an hourly close outside the $0.42-$0.38 range.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> is on the verge of a 22% price movement. An hourly close outside of the $0.42-$0.38 pocket will determine the direction of the breakout. <a href="https://t.co/nAu6OHpShM">pic.twitter.com/nAu6OHpShM</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1857127197711978699?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader Scient plans to long DOGE at $0.34, noting a possible wick to $0.32 but <a href="https://x.com/Crypto_Scient/status/1857375992441889047">expects</a> higher prices next week if $0.34 holds. 
Another trader, Cantonese Cat, analyzed the DOGE weekly chart and <a href="https://x.com/cantonmeow/status/1857201728816312708">predicted</a> "another 3-4 weeks to accumulate at this level before shooting up, possibly to $4?"
Crypto trader Kevin <a href="https://x.com/Kev_Capital_TA/status/1857212900827595071">identifies</a> $0.30-$0.26 as Dogecoin's key support zone, aligning with the golden pocket retracement. This 30-40% correction from the local top is seen as a healthy pullback during a bull market.
Statistics: IntoTheBlock data shows large transaction volume increasing by 41.1% and daily active addresses up by 34.9%. Transactions greater than $100,000 are up from 3,230 to 4,997 in a single day. Meanwhile, Martinez <a href="https://x.com/ali_charts/status/1857356986846752804">noted</a> Dogecoin whales purchased 140 million DOGE, worth $56 million, in the past 24 hours.
Community News: Binance Japan has <a href="https://www.binance.com/en/support/announcement/binance-launches-zero-fee-spot-trading-campaign-for-ada-jpy-doge-jpy-xrp-jpy-pairs-e41fc39b35da4d64b2b0c6aa768b7460?hl=en">launched</a> a zero-fee spot trading promotion for XRP, Dogecoin and Cardano against the Japanese Yen, running from Nov. 15 to Nov. 27.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41951069/dogecoins-flat-inflation-is-a-feature-not-a-bug-says-elon-musk">Dogecoin&#8217;s Flat Inflation Is &#8216;A Feature, Not A Bug,&#8217; Says Elon Musk</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Dogecoin Down 9%: What Is Going On?

- Data Vault's CEO to join today's Q3 2024 conference call to discuss its commercialization strategy –
WiSA Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>), which is in a definitive agreement to acquire AI, blockchain and Data Web 3.0 IP assets of Data Vault Holdings, Inc.&#xAE; ("Data Vault") to form a data technology &amp; licensing company leveraging IP &amp; proprietary HPC software, today filed a Preliminary Proxy Statement for its Annual Meeting, which included information regarding its planned acquisition of Data Vault's ADIO&#xAE; and Data Vault assets (the "Asset Purchase"). In its Q3 2024 conference call and presentation today at 8:00 am PT / 11:00 am ET, Data Vault's CEO Nate Bradley will also be joining to discuss recent news and the commercialization strategy.
The Asset Purchase Agreement
On September 4, 2024, as amended on November 14, 2024, WiSA Technologies executed a $210 million Definitive Agreement to purchase assets, including High-Performance Computing (HPC) software and acoustic technologies IP, from Data Vault, to create a licensing and technology company with an extensive patent portfolio serving multiple industry and government entities in bioengineering, energy, education, finance &amp; fintech, healthcare, sports entertainment, consumer, restaurants, automotive, and more. The $210 million purchase price consists of 40 million shares of WiSA common stock to be issued at $5 per share plus a $10 million 3-year Note, along with a 3% royalty on applicable product revenues.

WISA

WiSA Technologies Files Preliminary Proxy, Advancing Planned Acquisition Of Data Vault's ADIO And Data Vault Assets

<a href="https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm" title="https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm">https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm</a>

LWAY

Danone North America PBC Sent Second Letter To Lifeway Foods To Express Disappointment In Board's Response To Initial Proposal; Reiterates Danone North America PBC's Strong Commitment To Proposed Transaction; Updated Proposal, Danone North America PBC Increased Offer For Proposed Transaction From $25.00/Share To $27.00/Share

Goldman Sachs analyst George Tong maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Sell and raises the price target from $11.3 to $12.9.

Goldman Sachs Maintains Sell on BrightView Hldgs, Raises Price Target to $12.9

Allurion Technologies

The Beachbody Company, Inc. Class A Common Stock

Beachbody Co

Carriage Servs

E-Home Household Service Holdings Limited - Ordinary shares

E-Home Household Service

European Wax Center, Inc. - Class A Common Stock

European Wax Center

Frontdoor

H&R Block

Junee

Mister Car Wash

Alta Global Group Limited Ordinary Shares

Alta Global Group

OneSpaWorld Holdings Limited - Common Shares

OneSpaWorld Holdings

Wag Group

Regis

Service Corporation International Common Stock

Service Corp Intl

SunCar Technology Group Inc. - Ordinary Shares

Comments

MEDIROM Healthcare Techs

MEDIROM Healthcare Techs (MRM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga